MARKET

SPRB

SPRB

Spruce Biosciences, Inc.
NASDAQ
81.00
+0.33
+0.41%
Opening 09:30 12/16 EST
OPEN
80.00
PREV CLOSE
80.67
HIGH
81.00
LOW
80.00
VOLUME
803
TURNOVER
--
52 WEEK HIGH
240.00
52 WEEK LOW
4.275
MARKET CAP
86.70M
P/E (TTM)
-0.9570
1D
5D
1M
3M
1Y
5Y
1D
Spruce Biosciences Files Initial Beneficial Ownership Statement for Director Keli Walbert
Reuters · 14h ago
Spruce Biosciences Appoints Keli Walbert as Director
TipRanks · 1d ago
Spruce Biosciences Sets New Director Compensation Terms with Stock Options and Retainers
Reuters · 1d ago
SPRUCE BIOSCIENCES APPOINTS PROVEN PHARMACEUTICAL COMMERCIAL LEADER KELI WALBERT TO BOARD OF DIRECTORS
Reuters · 1d ago
*Spruce Biosciences Appoints Keli Walbert to Board of Directors
Dow Jones · 1d ago
Weekly Report: what happened at SPRB last week (1208-1212)?
Weekly Report · 1d ago
Spruce Biosciences Announces Board Resignation and Stock Repricing
TipRanks · 3d ago
Spruce Biosciences Reprices Stock Options to Boost Employee Retention
Reuters · 3d ago
More
About SPRB
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing therapies for neurological disorders with significant unmet medical need. The Company has acquired an exclusive worldwide license agreement for tralesinidase alfa enzyme replacement therapy (TA-ERT) for the treatment of Sanfilippo Syndrome Type B (MPS IIIB). The TA-ERT is a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase (rhNAGLU) with modified human insulin-like growth factor 2 via an amino acid linker. TA-ERT is intended as an enzyme replacement therapy for the treatment of patients with MPS IIIB who lack rhNAGLU enzyme activity. The Company's pipeline also includes Tildacerfont and Cortibon for the treatment of Major Depressive Disorder, SPR202 for the treatment of Congenital Adrenal Hyperplasia and SPR204 for the treatment of Post-Bariatric Hypoglycemia.

Webull offers Spruce Biosciences Inc stock information, including NASDAQ: SPRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPRB stock methods without spending real money on the virtual paper trading platform.